Showing results (51-60 of 451) with videos related to
Sort By:
Pageof 46
Cancer Research|September 1, 1990
In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumorsL Rivoltini, C Gambacorti-Passerini, M Squadrelli-Saraceno, et al.Cancer Research|September 15, 1989
Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin 2: possible role for lymphokine-activated killer cell infusion in the in vivo-induced activationC Gambacorti-Passerini, L Rivoltini, M Radrizzani, et al.Melanoma Research|November 1, 1992
Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot studyF Belli, F Arienti, L Rivoltini, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1992
Expansion of major histocompatibility complex-restricted antimelanoma cytotoxic T-cell lymphocyte clones with identical T-cell receptor from tumor-infiltrating lymphocytesM Sensi, C Castelli, S Salvi, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Involvement of somatically acquired ecotropic viruses in the immunogenicity of nude-transplanted NIH/3T3 transformed cell linesM Sensi, M Bergomi, P Panceri, et al.International Journal of Cancer|October 23, 1997
Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cellsV Ramakrishna, D R Negri, V Brusic, et al.International Journal of Cancer|December 2, 1991
Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactionsM Radrizzani, B Benedetti, C Castelli, et al.Immunology Today|November 1, 1993
Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cellsG ParmianiEuropean Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Future perspectives in specific immunotherapy of melanomaG ParmianiHuman Gene Therapy|October 20, 1996
Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cellsF Arienti, J Sulé-Suso, F Belli, et al.Pageof 46